Search Results - "Bermejo, A Campini"

Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer by Lluch-Gómez, J., Núñez-Álvarez, V., de la Torre-Hita, C., Bernal-Gómez, M., Campini-Bermejo, A., Perdomo-Zaldívar, E., Rodríguez-Pérez, L., Calvete-Candenas, J., Martínez-Bautista, M. J., Benítez-Rodríguez, E., Baena-Cañada, J. M.

“…Adjuvant trastuzumab in HER2+ breast cancer reduces recurrence and mortality, and has been the standard treatment since 2006. The objective was to analyze…”
Get full text

282PIdentification of ultralow risk breast cancer patients (probable overdiagnosis) by Casado, S Gamez, Gómez, M Bernal, Bermejo, A Campini, Perez, L Rodriguez, Quilez, A, Candenas, J Calvete, Bernal, G Martínez, Rodríguez, E Benítez, Baena-Canada, J M

“…Abstract Background The universalisation of mammographic screening has caused an increase in ultralow risk breast cancer diagnosis. Identifying subgroups with…”
Get full text

282P - Identification of ultralow risk breast cancer patients (probable overdiagnosis) by Casado, S Gamez, Gómez, M Bernal, Bermejo, A Campini, Perez, L Rodriguez, Quilez, A., Candenas, J Calvete, Bernal, G Martínez, Rodríguez, E Benítez, Baena-Canada, J.M.

“…The universalisation of mammographic screening has caused an increase in ultralow risk breast cancer diagnosis. Identifying subgroups with no events related to…”
Get full text

Identification of ultralow risk breast cancer patients (probable overdiagnosis) by Casado, S Gamez, Gómez, M Bernal, Bermejo, A Campini, Perez, L Rodriguez, Quilez, A., Candenas, J Calvete, Bernal, G Martínez, Rodríguez, E Benítez, Baena-Canada, J.M.

Get full text